PLoS ONE · 2020 · 10 citations · 48 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunoregulationTransplant ImmunologyDendritic Cell BiologyT Cell BiologyAllograft Survival AssessmentBone Marrow - Derived CellsCell Surface GlycoproteinsDendritic Cell-mediated T Cell ActivationDendritic Cell-t Cell InteractionGraft Survival EnhancementHeparan Sulfate ProteoglycansMixed Lymphocyte Reaction
Syndecan-1 (Sdc-1) is a heparan sulfate proteoglycan that can bind cytokines and chemokines via its heparan sulfate side chains, and has immunomodulatory properties in experimental models. Sdc-1 expression has been reported on dendritic cells (DC) and T cells. The potential role of Sdc-1 in DC-T cell interaction has not been investigated yet. We postulate that Sdc-1 is involved in DC-T cell interaction and may influence graft survival in an allogeneic transplant model. Sdc-1 expression on bone marrow-derived DC and T cells was analyzed by flow cytometry. Unstimulated and LPS stimulated Sdc-1 deficient DC were evaluated in vitro for phenotype and stimulatory capacity in mixed lymphocyte reaction. Sdc-1 deficient T cells were evaluated for proliferative capacity and differentiation in a mixed lymphocyte reaction and a proliferation assay. Allograft survival was evaluated in a fully MHC mismatched heterotopic heart transplant model, with either Sdc-1 deficient donors or recipients. Sdc-1 was expressed on the cell surface of unstimulated and LPS matured DC. Sdc-1 deficiency had no effect on expression of co-stimulatory molecules, cytokine production or T cell stimulatory capacity as compared to WT DC. Sdc-1 expression was not detectable on WT T cells, although intracellular Sdc-1 expression could be demonstrated after ConA activation. Sdc-1 deficient T cells showed reduced proliferation upon DC or ConA stimulation and reduced IL-17 production upon ConA stimulation, compared to WT T cells. Sdc-1 deficiency of either allograft or recipient did not prolong allograft survival. In conclusion, Sdc-1 is expressed on the cell surface of DC, where its absence does not affect DC phenotype or T cell stimulatory capacity. Sdc-1 is intracellularly expressed in ConA activated T cells. Sdc-1 deficiency in T cells results in a reduced proliferative response in vitro, as induced by DC and ConA. Sdc-1 deficiency in donor or recipient does not affect allograft survival.
48
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
Caroline M. Alexander, Frieda Reichsman, Michael T. Hinkes et al. · Nature Genetics · 2000 · 367 citations
Physiological Regulation of the Immunological Synapse by Agrin
Adil Aziz Khan, Christian Böse, Lung S. Yam et al. · Science · 2001 · 179 citations
Heart transplantation in congenic strains of mice.
Robert J. Corry, Henry J. Winn, P. S. Russell · PubMed · 1973 · 129 citations